Supernus Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

101,030

Value ($000)

5,021

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,021	0.0%	101,030	12/31/2025
2025 Q3	11/14/2025	4,828	0.0%	101,022	9/30/2025
2025 Q2	8/14/2025	5,286	0.0%	167,692	6/30/2025
2025 Q1	5/19/2025	3,530	0.0%	107,789	3/31/2025
2024 Q4	2/14/2025	3,617	0.0%	100,020	12/31/2024
2024 Q3	11/14/2024	2,501	0.0%	80,196	9/30/2024
2024 Q2	8/14/2024	2,475	0.0%	92,539	6/30/2024
2024 Q1	5/15/2024	1,752	0.0%	51,367	3/31/2024
2023 Q4	2/14/2024	1,487	0.0%	51,367	12/31/2023
2023 Q3	11/13/2023	1,316	0.0%	47,734	9/30/2023
2023 Q2	8/11/2023	2,014	0.0%	55,582	6/30/2023
2023 Q1	5/15/2023	2,014	0.0%	55,582	3/31/2023
2022 Q4	2/14/2023	2,038	0.0%	57,142	12/31/2022
2022 Q3	11/14/2022	1,987	0.0%	58,697	9/30/2022
2022 Q2	8/12/2022	1,522	0.0%	52,621	6/30/2022
2022 Q1	5/16/2022	1,731	0.0%	53,565	3/31/2022
2021 Q4	2/14/2022	1,282	0.0%	43,976	12/31/2021
2021 Q3	11/15/2021	1,208	0.0%	45,285	9/30/2021
2021 Q2	8/16/2021	1,394	0.0%	45,285	6/30/2021
2021 Q1	5/14/2021	1,116	0.0%	42,630	3/31/2021
2020 Q4	3/1/2021	1,073	0.0%	42,630	12/31/2020
2020 Q3	11/13/2020	888	0.0%	42,630	9/30/2020
2020 Q2	8/14/2020	1,012	0.0%	42,630	6/30/2020
2020 Q1	5/15/2020	557	0.0%	30,987	3/31/2020
2019 Q4	2/14/2020	975	0.0%	41,101	12/31/2019